Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity

Oncotarget

Volumn 7, Issue 13, 2016, Pages 15369-15381

  Bauman, Yoav ^a   Drayman, Nir ^a   Ben Nun Shaul, Orly ^a   Vitenstein, Alon ^a   Yamin, Rachel ^a   Ophir, Yael ^a   Oppenheim, Ariella ^a   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Immune response; Immune evasion; Immunity; Immunology and microbiology section; NK cells; NKG2D; SV40; ULBP1

Indexed keywords

AGNOPROTEIN; CAPSID PROTEIN; LIGAND; MESSENGER RNA; NATURAL KILLER CELL RECEPTOR NKG2D; ULBP1 PROTEIN; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; SIGNAL PEPTIDE; ULBP1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE EVASION; MCF 7 CELL LINE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PROTEIN EXPRESSION; SIMIAN VIRUS 40; VIRUS CAPSID; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOTOXICITY; IMMUNOLOGY; NATURAL KILLER CELL; POLYOMAVIRUS INFECTION; VIRUS INFECTION;

ANIMALS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; GPI-LINKED PROTEINS; HUMANS; IMMUNE EVASION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

EID: 84971656000     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8085     Document Type: Article

References (44)

1. Arnon TI, Markel G, Mandelboim O. Tumor and viral recognition by natural killer cells receptors. Seminars in cancer biology. 2006; 16:348-358.
2. Cheent K, Khakoo SI. Natural killer cells: integrating diversity with function. Immunology. 2009; 126:449-457.
3. Pegram HJ, Andrews DM, Smyth MJ, Darcy PK, Kershaw MH. Activating and inhibitory receptors of natural killer cells. Immunology and cell biology. 2011; 89:216-224.
4. Bottino C, Castriconi R, Moretta L, Moretta A. Cellular ligands of activating NK receptors. Trends in immunology. 2005; 26:221-226.
5. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 2001; 409:1055-1060.
6. Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A. Surface NK receptors and their ligands on tumor cells. Seminars in immunology. 2006; 18:151-158.
7. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nature reviews Immunology. 2003; 3:781-790.
8. Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunological reviews. 2010; 235:267-285.
9. Cerwenka A, Lanier LL. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue antigens. 2003; 61:335-343.
10. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell host & microbe. 2009; 5:376-385.
11. Slavuljica I, Krmpotic A, Jonjic S. Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response. Frontiers in immunology. 2011; 2:85.
12. Thomas M, Boname JM, Field S, Nejentsev S, Salio M, Cerundolo V, Wills M, Lehner PJ. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105:1656-1661.
13. Johnson EM. Structural evaluation of new human polyomaviruses provides clues to pathobiology. Trends in microbiology. 2010; 18:215-223.
14. Sariyer IK, Saribas AS, White MK, Safak M. Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content. Virology journal. 2011; 8:255.
15. White MK, Gordon J, Khalili K. The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. PLoS Pathog. 2013; 9:e1003206.
16. Pinto M, Dobson S. BK and JC virus: a review. J Infect. 2014; 68 Suppl 1:S2-8.
17. Samimi M, Gardair C, Nicol JT, Arnold F, Touze A, Coursaget P. Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectives. Semin Oncol. 2015; 42:347-358.
18. van der Meijden E, Janssens RW, Lauber C, Bouwes Bavinck JN, Gorbalenya AE, Feltkamp MC. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog. 2010; 6:e1001024.
19. Saracho Cornet PL, Traversaro M, Courel J, Buteler G, Moreno P, Ferreo G, Arias M. Cervical ectopic thymus [Article in Spanish]. Rev Fac Cien Med Univ Nac Cordoba. 1999; 56:119-122.
20. Shah KV. SV40 and human cancer: a review of recent data. Int J Cancer. 2007; 120:215-223.
21. Garcea RL, Imperiale MJ. Simian virus 40 infection of humans. J Virol. 2003; 77:5039-5045.
22. Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N, Stern-Ginossar N, Lankry D, Gruda R, Mandelboim O. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell host & microbe. 2011; 9:93-102.
23. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature. 2005; 435:682-686.
24. Kruse PH, Matta J, Ugolini S, Vivier E. Natural cytotoxicity receptors and their ligands. Immunology and cell biology. 2014; 92:221-229.
25. Seidel E, Glasner A, Mandelboim O. Virus-mediated inhibition of natural cytotoxicity receptor recognition. Cellular and molecular life sciences. 2012; doi:10.1007/s00018-012-1001-x.
26. Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999; 96:5640-5644.
27. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature. 1998; 391:397-401.
28. Halenius A, Gerke C, Hengel H. Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets-but how many arrows in the quiver? Cell Mol Immunol. 2015; 12:139-153.
29. Fanning E. Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture. Journal of virology. 1992; 66:1289-1293.
30. Nakanishi A, Itoh N, Li PP, Handa H, Liddington RC, Kasamatsu H. Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome. Journal of virology. 2007; 81:3778-3785.
31. Spear P, Wu MR, Sentman ML, Sentman CL. NKG2D ligands as therapeutic targets. Cancer Immun. 2013; 13:8.
32. Lowe DB, Shearer MH, Aldrich JF, Winn RE, Jumper CA, Kennedy RC. Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen. Journal of virology. 2010; 84:10121-10130.
33. Farrell ML, Mertz JE. Hormone response element in SV40 late promoter directly affects synthesis of early as well as late viral RNAs. Virology. 2002; 297:307-318.
34. Arad U, Zeira E, El-Latif MA, Mukherjee S, Mitchell L, Pappo O. Liver-targeted gene therapy by SV40-based vectors using the hydrodynamic injection method. Hum Gene Ther. 2005; 16:361-371.
35. Drayman N, Kler S, Ben-nun-Shaul O, Oppenheim A. Rapid method for SV40 titration. Journal of virological methods. 2010; 164:145-147.
36. Sandalon Z, Oppenheim A. Self-assembly and protein-protein interactions between the SV40 capsid proteins produced in insect cells. Virology. 1997; 237:414-421.
37. Mukherjee S, Abd-El-Latif M, Bronstein M, Ben-nun-Shaul O, Kler S, Oppenheim A. High cooperativity of the SV40 major capsid protein VP1 in virus assembly. PloS one. 2007; 2:e765.
38. Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, Katz G, Bar-Ilan A, Bloushtain N, Lev M, Joseph A, Kedar E, Porgador A, Mandelboim O. The mechanisms controlling the recognition of tumor-and virus-infected cells by NKp46. Blood. 2004; 103:664-672.
39. Mandelboim O, Reyburn HT, Vales-Gomez M, Pazmany L, Colonna M, Borsellino G, Strominger JL. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med. 1996; 184:913-922.
40. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. Journal of immunological methods. 2004; 294:15-22.
41. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, Holstege FC, Brummelkamp TR, Agami R, Clevers H. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 2003; 4:609-615.
42. Xu K, Ma H, McCown TJ, Verma IM, Kafri T. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther. 2001; 3:97-104.
43. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA. 2003; 9:493-501.
44. Drayman N, Oppenheim A. Rapid titration of viruses by flow cytometry. Current protocols in cell biology/editorial board, Juan S Bonifacino. 2011; Chapter 26:Unit 26 11.